Consumer groups, anti-trust watchdogs, public officials and pharmacy groups have expressed serious skepticism that an Express Scripts and Medco merger would result in cost savings for consumers, employers and the health plan clients of the drug benefit middlemen.  Now, add Washington Post columnist Steven Pearlstein to the list of those voicing caution about believing the claims of Express Scripts and Medco.